Skip to Content

267 Results Found

  • Systematic Review
  • Open Access
9 Citations
6,595 Views
19 Pages

22 December 2023

Lower urinary tract symptoms (LUTS) and hematuria are common symptoms in men with neoplasms, mainly affecting the elderly population. Prostatic arterial embolization (PAE) is a minimally invasive procedure that has shown promising results in managing...

(This article belongs to the Section Nephrology & Urology)
  • Review
  • Open Access
18 Citations
8,081 Views
25 Pages

The role of nuclear medicine in the management of oncological patients has expanded during last two decades. The number of radiopharmaceuticals contributing to the realization of theranostics/radiotheranostics in the context of personalized medicine...

(This article belongs to the Special Issue The Future Direction of Radiopharmaceutical Development for Cancer Theranostics)
  • Systematic Review
  • Open Access
3 Citations
3,160 Views
20 Pages

Normal Weight, Overweight and Obesity Conditions Associated to Prostate Neoplasm Stages—A Systematic Review and Meta-Analysis

  • Elsa Vitale,
  • Alessandro Rizzo,
  • Kurvatteppa Halemani,
  • Asha P. Shetty and ,
  • Omar Cauli,
  • Francesco Massari and
  • Matteo Santoni
  • + 2 authors+ 0 author

Background/Objective: Prostate cancer (PCa) represents the second-most common cancer among men worldwide. Obesity is generally considered as a risk factor for cancer and it has been associated with a 20–30% increased risk of PCa death. The pres...

(This article belongs to the Section Endocrinology and Metabolism Research)
  • Review
  • Open Access
14 Citations
4,975 Views
14 Pages

PSMA PET/CT in Castration-Resistant Prostate Cancer: Myth or Reality?

  • Luca Urso,
  • Luca Filippi,
  • Angelo Castello,
  • Maria Cristina Marzola and ,
  • Mirco Bartolomei,
  • Corrado Cittanti,
  • Luigia Florimonte,
  • Massimo Castellani,
  • Paolo Zucali and
  • Laura Evangelista
  • + 9 authors+ 4 authors

16 November 2023

Background: prostate-specific membrane antigen (PSMA) ligand PET has been recently incorporated into international guidelines for several different indications in prostate cancer (PCa) patients. However, there are still some open questions regarding...

(This article belongs to the Section Nuclear Medicine & Radiology)
  • Interesting Images
  • Open Access
676 Views
3 Pages

A 75-year-old man with newly diagnosed high-risk prostate cancer (cT3bN0M0) underwent 18F-PSMA PET/CT, which demonstrated intense tracer uptake in a left tracheal mass causing near-complete luminal obstruction, raising suspicion of a primary lung mal...

(This article belongs to the Topic Prostate Cancer: Symptoms, Diagnosis & Treatment—3rd Edition)
  • Editorial
  • Open Access
8 Citations
3,916 Views
4 Pages

Theranostics in Oncology—Thriving, Now More than Ever

  • Rudolf A. Werner,
  • Takahiro Higuchi,
  • Martin G. Pomper and
  • Steven P. Rowe

Tracing its roots back to the 1940s, theranostics in nuclear oncology has proved successful mainly due to the beneficial effects of image-guided therapeutic concepts for patients afflicted with a variety of different cancers. The majority of these tr...

(This article belongs to the Special Issue Novel Theranostic Agents)
  • Case Report
  • Open Access
3,154 Views
15 Pages

18 February 2025

Background: Metastatic castration-resistant prostate cancer (mCRPC) remains challenging due to progression despite androgen deprivation therapy (ADT). Current treatments, including androgen receptor-targeted agents, chemotherapy, bone-targeted agents...

(This article belongs to the Section Genitourinary Oncology)
  • Review
  • Open Access
8 Citations
2,610 Views
14 Pages

8 October 2025

Prostate cancer (PC) has long been considered a disease of older men. Still, a significant and concerning rise in diagnoses among younger men has revealed a biologically distinct and more aggressive clinical entity: early-onset prostate cancer (EO-PC...

(This article belongs to the Collection Latest Review Papers in Molecular Oncology)
  • Case Report
  • Open Access
4 Citations
2,913 Views
9 Pages

Incorporating VR-RENDER Fusion Software in Robot-Assisted Partial Prostatectomy: The First Case Report

  • Che-Hsueh Yang,
  • Li-Hsun Chen,
  • Yi-Sheng Lin,
  • Chao-Yu Hsu and ,
  • Min-Che Tung,
  • Shih-Wei Huang,
  • Chi-Hsiang Wu and
  • Yen-Chuan Ou
  • + 3 authors+ 0 author

31 January 2023

Currently, the active surveillance of men with favorable intermediate-risk localized prostate cancer (PCa) is a longstanding controversy, in terms of their oncological outcomes, and radical prostatectomy would constitute a similar concern of overtrea...

(This article belongs to the Special Issue Radical Surgery Advances in Oncology)
  • Article
  • Open Access
14 Citations
3,420 Views
14 Pages

Local Control after Locally Ablative, Image-Guided Radiotherapy of Oligometastases Identified by Gallium-68-PSMA-Positron Emission Tomography in Castration-Sensitive Prostate Cancer Patients (OLI-P)

  • Tobias Hölscher,
  • Michael Baumann,
  • Jörg Kotzerke,
  • Klaus Zöphel and ,
  • Frank Paulsen,
  • Arndt-Christian Müller,
  • Daniel Zips,
  • Christian Thomas,
  • Manfred Wirth and
  • Fabian Lohaus
  • + 8 authors+ 3 authors

21 April 2022

Progression of prostate-specific antigen (PSA) values after curative treatment of prostate cancer patients is common. Prostate-specific membrane antigen (PSMA-) PET imaging can identify patients with metachronous oligometastatic disease even at low P...

(This article belongs to the Special Issue New Advances in Metastatic Prostate Cancer)
  • Article
  • Open Access
20 Citations
5,280 Views
11 Pages

Epidemiological Characteristics and Survival in Patients with De Novo Metastatic Prostate Cancer

  • Carlo Cattrini,
  • Davide Soldato,
  • Alessandra Rubagotti,
  • Linda Zinoli and ,
  • Elisa Zanardi,
  • Paola Barboro,
  • Carlo Messina,
  • Elena Castro,
  • David Olmos and
  • Francesco Boccardo
  • + 5 authors+ 0 author

3 October 2020

The real-world outcomes of patients with metastatic prostate cancer (mPCa) are largely unexplored. We investigated the trends in overall survival (OS) and cancer-specific survival (CSS) in patients with de novo mPCa according to distinct time periods...

(This article belongs to the Special Issue Urological Cancer 2020)
  • Case Report
  • Open Access
106 Views
11 Pages

12 November 2026

Prostate-specific membrane antigen (PSMA) positron emission tomography (PET) detects recurrent prostate cancer at low prostate-specific antigen (PSA) levels, and PSMA-radioguided surgery (PSMA-RGS) localizes PSMA-avid tissue intraoperatively with a g...

  • Article
  • Open Access
112 Views
11 Pages

12 November 2026

Background/Objectives: This study aimed to evaluate the incremental value of systematic biopsy (SB) in addition to targeted biopsy (TB) and its impact on Grade Group (GG) reclassification in patients with Prostate Imaging Reporting and Data System (P...

(This article belongs to the Special Issue Clinical Diagnosis and Prognosis of Urologic Oncology)
  • Review
  • Open Access
15 Citations
13,785 Views
17 Pages

Predictive Value and Therapeutic Significance of Somatic BRCA Mutation in Solid Tumors

  • Gyongyver Szentmartoni,
  • Dorottya Mühl,
  • Renata Csanda,
  • Attila Marcell Szasz and ,
  • Zoltan Herold and
  • Magdolna Dank
  • + 1 author+ 0 author

Ten percent of patients with breast cancer, and probably somewhat more in patients with ovarian cancer, have inherited germline DNA mutations in the breast and ovarian cancer genes BRCA1 and BRCA2. In the remaining cases, the disease is caused by acq...

(This article belongs to the Special Issue Feature Reviews in Cancer Biomarkers)
  • Review
  • Open Access
7 Citations
3,277 Views
13 Pages

Fluorescence Confocal Microscopy in Urological Malignancies: Current Applications and Future Perspectives

  • Luca Ongaro,
  • Giulio Rossin,
  • Arianna Biasatti,
  • Matteo Pacini and ,
  • Michele Rizzo,
  • Fabio Traunero,
  • Andrea Piasentin,
  • Alessandro Perotti,
  • Carlo Trombetta and
  • Francesco Claps
  • + 10 authors+ 5 authors

5 December 2023

Fluorescence confocal microscopy (FCM) represents a novel diagnostic technique able to provide real-time histological images from non-fixed specimens. As a consequence of its recent developments, FCM is gaining growing popularity in urological practi...

(This article belongs to the Section Medical Research)
  • Article
  • Open Access
3 Citations
1,511 Views
12 Pages

Electronic Health Literacy, Psychological Distress, and Quality of Life in Urological Cancer Patients: A Longitudinal Study During Transition from Inpatient to Outpatient Care

  • Dominik Fugmann,
  • Steffen Holsteg,
  • Ralf Schäfer,
  • Günter Niegisch and ,
  • Ulrike Dinger and
  • André Karger
  • + 1 author+ 0 author

13 November 2025

Urological cancers are associated with reduced quality of life and high psychological burden, yet affected patients receive less psychosocial support than other cancer groups. Electronic health literacy (eHL) may facilitate independent access to reso...

(This article belongs to the Section Psychosocial Oncology)
  • Article
  • Open Access
27 Citations
1,856 Views
11 Pages

Estimating the Costs of Intensity-Modulated and 3-Dimensional Conformal Radiotherapy in Ontario

  • J.H.E. Yong,
  • T. McGowan,
  • R. Redmond-Misner,
  • J. Beca and ,
  • P. Warde,
  • E. Gutierrez and
  • J.S. Hoch
  • + 2 authors+ 0 author

1 June 2016

Background: Radiotherapy is a common treatment for many cancers, but up-to-date estimates of the costs of radiotherapy are lacking. In the present study, we estimated the unit costs of intensity-modulated radiotherapy (imrt) and 3-dimensional conform...

  • Review
  • Open Access
15 Citations
5,876 Views
20 Pages

Current Applications and Future Development of Magnetic Resonance Fingerprinting in Diagnosis, Characterization, and Response Monitoring in Cancer

  • Hao Ding,
  • Carlos Velasco,
  • Huihui Ye,
  • Thomas Lindner and ,
  • Matthew Grech-Sollars,
  • James O’Callaghan,
  • Crispin Hiley,
  • Manil D. Chouhan,
  • Thoralf Niendorf and
  • Sola Adeleke
  • + 7 authors+ 2 authors

22 September 2021

Magnetic resonance imaging (MRI) has enabled non-invasive cancer diagnosis, monitoring, and management in common clinical settings. However, inadequate quantitative analyses in MRI continue to limit its full potential and these often have an impact o...

(This article belongs to the Special Issue Feature Paper from Journal Reviewers)
  • Viewpoint
  • Open Access
8 Citations
5,938 Views
6 Pages

Prostatic Inflammation in Prostate Cancer: Protective Effect or Risk Factor?

  • Alessandro Tafuri,
  • Francesco Ditonno,
  • Andrea Panunzio,
  • Alessandra Gozzo and ,
  • Antonio Benito Porcaro,
  • Vittore Verratti,
  • Maria Angela Cerruto and
  • Alessandro Antonelli
  • + 3 authors+ 0 author

22 June 2021

The relationship between prostatic chronic inflammation (PCI) and prostate cancer (PCa) is unclear and controversial. Some authors reported that a history of chronic prostatitis may be correlated with PCa induction, while others associate chronic inf...

  • Article
  • Open Access
6 Citations
3,324 Views
8 Pages

Prostate artery embolization (PAE) is an emerging therapy for benign prostatic hyperplasia (BPH). Optimal patient selection is an important step when introducing new treatments and several characteristics associated with a good clinical outcome has p...

(This article belongs to the Special Issue New Trends in Vascular Imaging)
  • Review
  • Open Access
11 Citations
6,820 Views
13 Pages

22 August 2023

Prostate cancer is a common cancer among men and typically progresses slowly for several decades before becoming aggressive and spreading to other organs, leaving few treatment options. While large animals have been studied, the dog’s prostate...

(This article belongs to the Section Methods and Technologies Development)
  • Review
  • Open Access
646 Views
51 Pages

Prostate Cancer Research in Ghana: A Scoping Review of Research Direction and Priorities

  • Isaac Amoah,
  • Hannah Ayettey Anie,
  • Daniel Tetteh,
  • Vanessa Adu Sarpong and ,
  • Kwaku Addai Arhin Appiah and
  • Phyllis Tawiah
  • + 1 author+ 0 author

9 October 2026

Background: In Ghana, prostate cancer (PCa) was the second most frequently diagnosed cancer among men in 2022, after liver cancer. Despite increasing research interest, evidence needed to guide PCa research priorities remains fragmented. This scoping...

(This article belongs to the Section Clinical Research in Cancer)
  • Article
  • Open Access
9 Citations
6,386 Views
15 Pages

Detecting Clinically Significant Prostate Cancer in PI-RADS 3 Lesions Using T2w-Derived Radiomics Feature Maps in 3T Prostate MRI

  • Laura J. Jensen,
  • Damon Kim,
  • Thomas Elgeti,
  • Ingo G. Steffen and ,
  • Lars-Arne Schaafs,
  • Matthias Haas,
  • Lukas J. Kurz,
  • Bernd Hamm and
  • Sebastian N. Nagel
  • + 4 authors+ 0 author

1 November 2024

Prostate Imaging Reporting and Data System version 2.1 (PI-RADS) category 3 lesions are a challenge in the clinical workflow. A better detection of the infrequently occurring clinically significant prostate cancer (csPCa) in PI-RADS 3 lesions is an i...

(This article belongs to the Special Issue Shaping the Future of Oncology: The Role of Generative AI in Clinical and Research Environments)
  • Systematic Review
  • Open Access
10 Citations
6,062 Views
18 Pages

High-Intensity Focus Ultrasound Ablation in Prostate Cancer: A Systematic Review

  • Che-Hsueh Yang,
  • Daniela-Viviana Barbulescu,
  • Lucian Marian,
  • Min-Che Tung and ,
  • Yen-Chuan Ou and
  • Chi-Hsiang Wu
  • + 1 author+ 0 author

20 December 2024

Background/Objectives: Prostate cancer (PCa) outcomes vary significantly across risk groups. In early-stage localized PCa, the functional outcomes following radical prostatectomy (RP) can be severe, prompting increased interest in focal therapy, part...

(This article belongs to the Special Issue Urological Cancer: Clinical Advances in Personalized Therapy)
  • Article
  • Open Access
6 Citations
4,360 Views
10 Pages

Impact of Progressive Site-Directed Therapy in Oligometastatic Castration-Resistant Prostate Cancer on Subsequent Treatment Response

  • Soichiro Yoshida,
  • Taro Takahara,
  • Yuki Arita,
  • Kazuma Toda and ,
  • Koichiro Kimura,
  • Hajime Tanaka,
  • Minato Yokoyama,
  • Yoh Matsuoka,
  • Ryoichi Yoshimura and
  • Yasuhisa Fujii
  • + 5 authors+ 0 author

23 January 2022

The purpose of this study was to evaluate the impact of progressive site-directed therapy (PSDT) for oligometastatic castration-resistant prostate cancer (OM-CRPC) on the efficacy of subsequent androgen receptor axis-targeted (ARAT) drugs, and to dem...

(This article belongs to the Special Issue Oligometastatic Disease)
  • Review
  • Open Access
24 Citations
6,893 Views
16 Pages

Prostate MRI and PSMA-PET in the Primary Diagnosis of Prostate Cancer

  • Lorenzo Cereser,
  • Laura Evangelista,
  • Gianluca Giannarini and
  • Rossano Girometti

17 August 2023

Over the last years, prostate magnetic resonance imaging (MRI) has gained a key role in the primary diagnosis of clinically significant prostate cancer (csPCa). While a negative MRI can avoid unnecessary prostate biopsies and the overdiagnosis of ind...

(This article belongs to the Special Issue Medical Radiology in Italy: Current Progress)
  • Article
  • Open Access
6 Citations
7,084 Views
11 Pages

Reporting and Handling of Indeterminate Bone Scan Results in the Staging of Prostate Cancer: A Systematic Review

  • Lars J. Petersen,
  • Jesper Strandberg,
  • Louise Stenholt,
  • Martin B. Johansen and
  • Helle D. Zacho

Bone scintigraphy is key in imaging skeletal metastases in newly diagnosed prostate cancer. Unfortunately, a notable proportion of scans are not readily classified as positive or negative but deemed indeterminate. The extent of reporting of indetermi...

(This article belongs to the Special Issue Imaging of Bone Metastases in Oncology)
  • Article
  • Open Access
1 Citations
904 Views
15 Pages

Pre-Analytical and Analytical Challenges in Whole-Exome Sequencing of Formalin-Fixed Paraffin-Embedded Breast and Prostate Cancer Tissue: A Real-World Multicenter Study

  • Mahira L. Rosa,
  • Cláudia Bordignon,
  • Jaqueline B. Schuch,
  • Angélica C. Baumont and ,
  • Marina Bessel,
  • Giovana D. Curzel,
  • Nathan A. Cadore,
  • Ana Paula M. Varela,
  • Giovana T. dos Santos and
  • Gabriel S. Macedo
  • + 27 authors+ 22 authors

Background/Objectives: Formalin-fixed paraffin-embedded tissue is widely used in pathology and molecular diagnostics, yet its variable quality can critically influence the accuracy of sequencing-based analyses. This study investigated pre-analytical...

(This article belongs to the Special Issue Predictive Biomarkers in Oncology)
  • Article
  • Open Access
3 Citations
2,914 Views
9 Pages

Identifying Patients in Whom the Follow-Up Scheme after Robot-Assisted Radical Prostatectomy Could Be Optimized in the First Year after Surgery: Reducing Healthcare Burden

  • Hans Veerman,
  • Sophia H. van der Graaf,
  • Dennie Meijer,
  • Marinus J. Hagens and ,
  • Corinne N. Tillier,
  • Pim J. van Leeuwen,
  • Henk G. van der Poel and
  • André N. Vis
  • + 3 authors+ 0 author

Background: The currently advised follow-up scheme of PSA testing after robot-assisted radical prostatectomy (RARP) is strict and might pose a burden to our healthcare system. We aimed to optimize the 1-year follow-up scheme for patients who undergo...

(This article belongs to the Special Issue Prostate Cancer: From Pathology to Novel Therapeutic Approaches)
  • Review
  • Open Access
53 Citations
8,790 Views
16 Pages

Active Surveillance for Prostate Cancer: Past, Current, and Future Trends

  • Ivo I. de Vos,
  • Henk B. Luiting and
  • Monique J. Roobol

3 April 2023

In response to the rising incidence of indolent, low-risk prostate cancer (PCa) due to increased prostate-specific antigen (PSA) screening in the 1990s, active surveillance (AS) emerged as a treatment modality to combat overtreatment by delaying or a...

  • Article
  • Open Access
1 Citations
2,261 Views
7 Pages

Influence of Prostate Cancer on Thulium Vapoenucleation of the Prostate—A Multicentre Analysis

  • Tobias Lamersdorf,
  • Christopher Netsch,
  • Benedikt Becker,
  • Christian Wülfing and ,
  • Petra Anheuser,
  • Oliver Engel,
  • Andreas J. Gross and
  • Clemens Mathias Rosenbaum
  • + 3 authors+ 0 author

1 February 2023

Purpose: Prostate cancer (PCa) and benign prostatic hyperplasia (BPH) are common in elderly men. Data on the laser-based surgery known as thulium vapoenucleation of the prostate (ThuVEP) in PCa patients are rare. Our objective was to analyse the feas...

(This article belongs to the Section General Surgery)
  • Review
  • Open Access
2 Citations
4,676 Views
17 Pages

The main prostate cancer (PCa) treatments include surgery or radiotherapy (with or without ADT). However, none of the suggested treatments eliminates the risk of lymph node metastases. Conventional imaging methods, including MRI and CT scanning, are...

(This article belongs to the Special Issue Implementation of New Imaging Techniques, Biomarkers and New Treatments in Prostate Cancer)
  • Article
  • Open Access
4 Citations
4,086 Views
15 Pages

High Tumor Burden Predicts Poor Response to Enzalutamide in Metastatic Castration-Resistant Prostate Cancer Patients

  • Yu-Ting Hsieh,
  • Bing-Juin Chiang,
  • Chia-Chang Wu,
  • Chun-Hou Liao and ,
  • Chia-Da Lin and
  • Chung-Hsin Chen
  • + 1 author+ 0 author

5 August 2021

To assess the predictive value of tumor burden on the biochemical response, and radiological response in Taiwanese metastatic castration-resistant prostate cancer (mCRPC) patients receiving enzalutamide. The mCRPC patients treated with enzalutamide w...

(This article belongs to the Collection Prostate Cancer: Pathophysiology, Pathology and Therapy)
  • Article
  • Open Access
62 Citations
5,838 Views
14 Pages

SelectMDx and Multiparametric Magnetic Resonance Imaging of the Prostate for Men Undergoing Primary Prostate Biopsy: A Prospective Assessment in a Multi-Institutional Study

  • Martina Maggi,
  • Francesco Del Giudice,
  • Ugo G. Falagario,
  • Andrea Cocci and ,
  • Giorgio Ivan Russo,
  • Marina Di Mauro,
  • Giuseppe Salvatore Sepe,
  • Fabio Galasso,
  • Rosario Leonardi and
  • Gian Maria Busetto
  • + 16 authors+ 11 authors

23 April 2021

Prostate-specific antigen (PSA) testing as the sole indication for prostate biopsy lacks specificity, resulting in overdiagnosis of indolent prostate cancer (PCa) and missing clinically significant PCa (csPCa). SelectMDx is a biomarker-based risk sco...

  • Article
  • Open Access
7 Citations
3,374 Views
12 Pages

12 May 2021

Purpose: To evaluate the diagnostic performance of PI-RADS v2, proposed adjustments to PI-RADS v2 (PA PI-RADS v2) and biparametric magnetic resonance imaging (MRI) for prostate cancer detection. Methods: A retrospective cohort of 224 patients with su...

  • Article
  • Open Access
7 Citations
3,535 Views
10 Pages

Predictors of Bone Metastases at 68Ga-PSMA-11 PET/CT in Hormone-Sensitive Prostate Cancer (HSPC) Patients with Early Biochemical Recurrence or Persistence

  • Guido Rovera,
  • Serena Grimaldi,
  • Sara Dall’Armellina,
  • Roberto Passera and ,
  • Marco Oderda,
  • Giuseppe Carlo Iorio,
  • Alessia Guarneri,
  • Paolo Gontero,
  • Umberto Ricardi and
  • Désirée Deandreis
  • + 5 authors+ 0 author

Prostate-specific-membrane-antigen/positron-emission-tomography (PSMA-PET) can accurately detect disease localizations in prostate cancer (PCa) patients with early biochemical recurrence/persistence (BCR/BCP), allowing for more personalized image-gui...

(This article belongs to the Section Medical Imaging and Theranostics)
  • Article
  • Open Access
4 Citations
3,134 Views
10 Pages

Diagnostic Age, Age at Death and Stage Migration in Men Dying with or from Prostate Cancer in Denmark

  • Marc Casper Meineche Andersen,
  • Hein Vincent Stroomberg,
  • Klaus Brasso,
  • John Thomas Helgstrand and
  • Andreas Røder

The impact of changes in diagnostic activity and treatment options on prostate cancer epidemiology remains a subject of debate. Newly published long-term survival outcomes may not represent contemporary patients and new perspectives are in demand. Al...

(This article belongs to the Section Pathology and Molecular Diagnostics)
  • Systematic Review
  • Open Access
18 Citations
4,316 Views
15 Pages

Predicting Biochemical Recurrence of Prostate Cancer Post-Prostatectomy Using Artificial Intelligence: A Systematic Review

  • Jianliang Liu,
  • Haoyue Zhang,
  • Dixon T. S. Woon,
  • Marlon Perera and
  • Nathan Lawrentschuk

25 October 2024

Background/Objectives: Biochemical recurrence (BCR) after radical prostatectomy (RP) is a significant predictor of distal metastases and mortality in prostate cancer (PCa) patients. This systematic review aims to evaluate the accuracy of artificial i...

(This article belongs to the Special Issue Artificial Intelligence in Cancer Research: Knowledge Representation and Data Perspectives)
  • Article
  • Open Access
2 Citations
3,470 Views
12 Pages

4 December 2023

This research aimed to assess the relationship between contrast-enhanced (CE) magnetic resonance fingerprinting (MRF) values and dynamic contrast-enhanced (DCE) MRI parameters including (Ktrans, Kep, Ve, and iAUC). To evaluate the correlation between...

(This article belongs to the Special Issue Evolution of Treatments of Prostate Cancer: From Biology to Current Advanced Technologies)
  • Review
  • Open Access
16 Citations
5,773 Views
17 Pages

Influence of Androgen Deprivation Therapy on the Development of Sarcopenia in Patients with Prostate Cancer: A Systematic Review

  • Marta Stelmach-Mardas,
  • Wojciech Warchoł,
  • Aleksandra Garczyk,
  • Emilia Warchoł and ,
  • Jolanta Korczak,
  • Maria Litwiniuk,
  • Beata Brajer-Luftmann and
  • Marcin Mardas
  • + 3 authors+ 0 author

26 February 2024

The changes in body composition during androgen deprivation therapy (ADT) in patients suffering from prostate cancer (PCa) are recognized by professionals more often as biomarker for effective treatment. The aim of this study was to investigate the i...

(This article belongs to the Section Nutrition Methodology & Assessment)
  • Review
  • Open Access
4 Citations
5,989 Views
12 Pages

12 July 2024

In 2021, two randomized controlled trials (RCTs), TheraP and VISION, demonstrated that 177Lu-PSMA-617 as monotherapy was more effective for the decline of PSA than the comparator third-line treatments. Methods: Our review summarizes new RCTs that add...

(This article belongs to the Special Issue Clinical Outcomes in Urologic Cancers)
  • Article
  • Open Access
15 Citations
4,372 Views
11 Pages

Diffusion Is Directional: Innovative Diffusion Tensor Imaging to Improve Prostate Cancer Detection

  • Chen Shenhar,
  • Hadassa Degani,
  • Yaara Ber,
  • Jack Baniel and ,
  • Shlomit Tamir,
  • Ofer Benjaminov,
  • Philip Rosen,
  • Edna Furman-Haran and
  • David Margel
  • + 4 authors+ 0 author

In the prostate, water diffusion is faster when moving parallel to duct and gland walls than when moving perpendicular to them, but these data are not currently utilized in multiparametric magnetic resonance imaging (mpMRI) for prostate cancer (PCa)...

(This article belongs to the Special Issue Role of Imaging and Artificial Intelligence in Prostate Cancer)
  • Article
  • Open Access
10 Citations
2,945 Views
16 Pages

A Novel Framework for the Optimization of Simultaneous ThermoBrachyTherapy

  • Ioannis Androulakis,
  • Rob M. C. Mestrom,
  • Miranda E. M. C. Christianen,
  • Inger-Karine K. Kolkman-Deurloo and
  • Gerard C. van Rhoon

10 March 2022

In high-dose-rate brachytherapy (HDR-BT) for prostate cancer treatment, interstitial hyperthermia (IHT) is applied to sensitize the tumor to the radiation (RT) dose, aiming at a more efficient treatment. Simultaneous application of HDR-BT and IHT is...

(This article belongs to the Special Issue Oncologic Thermoradiotherapy: Need for Evidence, Harmonisation, and Innovation)
  • Article
  • Open Access
9 Citations
3,775 Views
13 Pages

Modeled Early Longitudinal PSA Kinetics Prognostic Value in Rising PSA Prostate Cancer Patients after Local Therapy Treated with ADT +/− Docetaxel

  • Aurore Carrot,
  • Reza-Thierry Elaidi,
  • Olivier Colomban,
  • Denis Maillet and ,
  • Michel Tod,
  • Benoit You and
  • Stéphane Oudard
  • + 2 authors+ 0 author

5 February 2022

Background: In metastatic prostate cancer (PCa) patients, androgen-deprivation therapy (ADT) combined with chemotherapy or next-generation androgen receptor targeted agents is a new standard treatment. The objective of the present study is to assess...

(This article belongs to the Collection Biomarkers for Detection and Prognosis of Prostate Cancer)
  • Systematic Review
  • Open Access
12 Citations
6,039 Views
12 Pages

A Systematic Review to Evaluate Patient-Reported Outcome Measures (PROMs) for Metastatic Prostate Cancer According to the COnsensus-Based Standard for the Selection of Health Measurement INstruments (COSMIN) Methodology

  • Maria Monica Ratti,
  • Giorgio Gandaglia,
  • Elena Silvia Sisca,
  • Alexandra Derevianko and ,
  • Eugenia Alleva,
  • Katharina Beyer,
  • Charlotte Moss,
  • Francesco Barletta,
  • Simone Scuderi and
  • Alberto Briganti
  • + 15 authors+ 10 authors

19 October 2022

Introduction: Patient-reported outcome measures (PROMs) represent important endpoints in metastatic prostate cancer (mPCa). However, the clinically valid and accurate measurement of health-related quality of life depends on the psychometric propertie...

  • Article
  • Open Access
37 Citations
5,075 Views
12 Pages

Exploring the Association between Gut and Urine Microbiota and Prostatic Disease including Benign Prostatic Hyperplasia and Prostate Cancer Using 16S rRNA Sequencing

  • Kai-Yen Tsai,
  • Deng-Chyang Wu,
  • Wen-Jeng Wu,
  • Jiunn-Wei Wang and ,
  • Yung-Shun Juan,
  • Ching-Chia Li,
  • Chung-Jung Liu and
  • Hsiang-Ying Lee
  • + 3 authors+ 0 author

Numerous microorganisms residing in the gastrointestinal and genitourinary tracts affect host health. We investigated stool and voided urine samples collected from patients with benign prostatic hyperplasia (BPH) or prostate cancer (PC) and a control...

(This article belongs to the Topic Clinical, Translational, Basic Researches, and Application of Bacterial Toxins on Bladder Diseases and Lower Urinary Tract Dysfunctions)
  • Review
  • Open Access
8 Citations
4,336 Views
15 Pages

Phloretin in Benign Prostate Hyperplasia and Prostate Cancer: A Contemporary Systematic Review

  • Che-Hsueh Yang,
  • Yen-Chuan Ou,
  • Chi-Chien Lin,
  • Yi-Sheng Lin and ,
  • Min-Che Tung,
  • Chia-Cheng Yu,
  • Jen-Tai Lin and
  • Chen-Yueh Wen
  • + 3 authors+ 0 author

11 July 2022

Currently, medication for benign prostate hyperplasia (BPH) and prostate cancer (PCa) are mainly based on modulating the hormone and nervous systems. However, side effects often affect patients, and might decrease their commitment to continuing the m...

(This article belongs to the Section Pharmaceutical Science)
  • Article
  • Open Access
13 Citations
4,826 Views
16 Pages

A Trial-Based Cost-Utility Analysis of Metastasis-Directed Therapy for Oligorecurrent Prostate Cancer

  • Elise De Bleser,
  • Ruben Willems,
  • Karel Decaestecker,
  • Lieven Annemans and ,
  • Aurélie De Bruycker,
  • Valérie Fonteyne,
  • Nicolaas Lumen,
  • Filip Ameye,
  • Ignace Billiet and
  • Renée Bultijnck
  • + 8 authors+ 3 authors

4 January 2020

The optimal management of patients with oligorecurrent prostate cancer (PCa) is unknown. There is growing interest in metastasis-directed therapy (MDT) for this population. The objective was to assess cost-utility from a Belgian healthcare payer&rsqu...

(This article belongs to the Special Issue Prostate Cancer Radiotherapy)
  • Review
  • Open Access
36 Citations
14,178 Views
17 Pages

5 January 2020

Elective gonadectomy in the dog is a topic of interest for clinicians, pet-owners, and society. Although canine prostatic neoplasia (CPN) has a low incidence (0.35%), reports of an increased risk for castrated dogs attract attention and cause concern...

(This article belongs to the Section Companion Animals)
  • Communication
  • Open Access
2 Citations
2,518 Views
8 Pages

The Rebound Effect of the COVID-19 Pandemic on Clinically Significant Prostate Cancer Diagnosis

  • Antonio Fanelli,
  • Ugo Giovanni Falagario,
  • Marco Finati,
  • Francesco Guzzi and ,
  • Antonella Ninivaggi,
  • Luca Montrone,
  • Angelo Cormio,
  • Oscar Selvaggio,
  • Pasquale Annese and
  • Giuseppe Carrieri
  • + 9 authors+ 4 authors

12 March 2025

Background and aim: The effect of the COVID-19 pandemic on delayed screening and consequent diagnosis of prostate cancer (PCa) is yet to be defined. This study aimed to evaluate the impact of the COVID-19 pandemic on PCa diagnosis by comparing the nu...

(This article belongs to the Section Applied Biosciences and Bioengineering)

of 6